Efficacy and safety of short-term use of a pelubiprofen CR and aceclofenac in patients with symptomatic knee osteoarthritis: A double-blinded, randomized, multicenter, active drug comparative, parallel-group, phase IV, non-inferiority clinical trial
Table 3
Primary efficacy outcome: analysis (adding site factor) of 100-mm pain VAS at week 4 (PP and FA sets).